DOMAIN | Preoperative symptoms/impact | No preoperative symptoms/impact | Symptoms better | Symptoms worse | No change in symptoms | p* |
---|---|---|---|---|---|---|
Urinary (n = 31) | ||||||
  Voiding | 21 (67.74%) | 10 (32.2%) | 16 (51.61%) | 8 (25.8%) | 7 (22.58%) | 0.120 |
  Impact of voiding | 19 (61.29%) | 12 (38.70%) | 15 (48.38%) | 3 (9.67%) | 13 (41.93%) | 0.014 |
  Pain and sensation | 20 (64.51%) | 11 (35.48%) | 12 (38.70%) | 6 (19.35%) | 13 (41.93%) | 0.189 |
  Impact of pain and sensation | 16 (51.61%) | 15 (48.38%) | 10 (32.2%) | 5 (16.12%) | 16 (51.61%) | 0.122 |
  Overactive bladder | 29 (93.54%) | 2 (6.45%) | 18 (58.06%) | 4 (12.90%) | 9 (29.03%) | 0.014 |
  Impact of overactive bladder | 25 (80.64%) | 6 (19.35%) | 17 (54.83%) | 3 (9.67%) | 11 (35.48%) | 0.004 |
  Stress urinary incontinence | 25 (80.64%) | 6 (19.35%) | 17 (54.83%) | 4 (12.90%) | 10 (32.2%) | 0.002 |
  Impact of stress incontinence | 22 (70.96%) | 9 (29.03%) | 13 (41.93%) | 2 (6.45%) | 16 (51.61%) | 0.005 |
  Quality of life | 24 (77.41%) | 7 (22.5%) | 19 (61.29%) | 1(3.22%) | 11 (35.48%) | 0.003 |
Bowel (n = 31) | ||||||
  Irritable bowel symptoms | 30 (96.77%) | 1 (3.22%) | 15 (48.38%) | 2 (6.45%) | 14 (45.16%) | 0.047 |
  Constipation | 18 (58.06%) | 13 (41.93%) | 12 (38.7%) | 3 (9.67%) | 16 (51.61%) | 0.063 |
  Evacuation | 29 (93.54%) | 2 (6.45%) | 20 (64.51%) | 4 (12.90%) | 7 (22.58%) | 0.014 |
  Impact of evacuation | 26 (83.87%) | 5 (16.12%) | 13 (41.93%) | 2 (6.45%) | 16 (51.61%) | 0.005 |
  Continence | 31 (100%) | 0 | 19 (61.29%) | 2 (6.45%) | 10 (32.2%) | 0.051 |
  Impact of continence | 24 (77.41%) | 7 (22.58%) | 14 (45.16%) | 1 (3.22%) | 16 (51.61%) | 0.005 |
  Quality of life | 16 (51.61%) | 15 (48.38%) | 14 (45.16%) | 3 (9.67%) | 14 (45.16%) | 0.013 |
Vagina (n = 31) | ||||||
  Pain | 29 (93.54%) | 2 (6.45%) | 25 (80.64%) | 3 (9.67%) | 3 (9.67%) | <0.001 |
  Impact of pain | 25 (80.64%) | 6 (19.35%) | 21 (67.74%) | 1 (3.22%) | 9 (29.03%) | <0.001 |
  Prolapse | 31 (100%) | 0 | 31 (100%) | 0 | 0 | <0.001 |
  Impact of prolapse | 29 (93.54%) | 2 (6.45%) | 29 (93.54%) | 0 | 2 (6.45%) | <0.001 |
  Quality of life | 29 (93.54%) | 2 (6.45%) | 27 (87.09%) | 1 (3.22%) | 3 (9.67%) | <0.001 |
Sexa (n = 10) | ||||||
  Sex overall | 10 (100%) | 0 | 8 (80%) | 0 | 2 (20%) | 0.004 |
  Sex and bladder | 10 (100%) | 0 | 10 (100%) | 0 | 0 | 0.002 |
  Impact of sex and bladder | 9 (90%) | 1 (10%) | 8 (80%) | 0 | 2 (20%) | 0.002 |
  Sex and bowel | 6 (60%) | 4 (40%) | 6 (60%) | 1 (10%) | 3 (30%) | 0.096 |
  Impact of sex and bowel | 4 (40%) | 6 (60%) | 4 (40%) | 0 | 6 (60%) | 0.099 |
  Sex and vagina | 9 (90%) | 1 (10%) | 9 (90%) | 0 | 1 (10%) | 0.007 |
  Impact of sex and vagina | 9 (90%) | 1 (10%) | 8 (80%) | 0 | 2 (20%) | 0.002 |
  Psychological status | 30 (96.77%) | 1 (3.22%) | 29 (93.54%) | 0 | 2 (6.45%) | <0.001 |